Wealthfront Advisers LLC Decreases Stock Position in Humana Inc. (NYSE:HUM)

Wealthfront Advisers LLC decreased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 35.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,896 shares of the insurance provider's stock after selling 7,184 shares during the period. Wealthfront Advisers LLC's holdings in Humana were worth $3,412,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Achmea Investment Management B.V. raised its holdings in Humana by 0.5% in the 1st quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after purchasing an additional 49 shares during the period. Beech Hill Advisors Inc. lifted its position in Humana by 6.1% during the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock valued at $229,000 after purchasing an additional 50 shares during the period. Deseret Mutual Benefit Administrators raised its position in shares of Humana by 15.8% in the first quarter. Deseret Mutual Benefit Administrators now owns 462 shares of the insurance provider's stock worth $122,000 after acquiring an additional 63 shares during the period. Vise Technologies Inc. raised its position in shares of Humana by 8.0% during the 4th quarter. Vise Technologies Inc. now owns 873 shares of the insurance provider's stock worth $221,000 after purchasing an additional 65 shares during the last quarter. Finally, Versant Capital Management Inc grew its stake in shares of Humana by 17.1% in the 1st quarter. Versant Capital Management Inc now owns 453 shares of the insurance provider's stock valued at $120,000 after buying an additional 66 shares during the period. Institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on HUM shares. Wall Street Zen lowered shares of Humana from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Barclays set a $268.00 price objective on shares of Humana and gave the company an "equal weight" rating in a research report on Thursday, June 12th. Truist Financial dropped their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research report on Wednesday. Bank of America decreased their price target on shares of Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a report on Tuesday, June 17th. Finally, Mizuho lifted their target price on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Seventeen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, Humana currently has a consensus rating of "Hold" and a consensus target price of $279.81.

Humana Trading Down 1.3%

HUM stock opened at $223.68 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.91 and a quick ratio of 1.91. The company has a market capitalization of $27.00 billion, a price-to-earnings ratio of 15.82, a PEG ratio of 1.55 and a beta of 0.44. Humana Inc. has a 1-year low of $212.45 and a 1-year high of $406.46. The business has a 50 day simple moving average of $235.46 and a two-hundred day simple moving average of $257.46.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The company had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. The firm's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $7.23 earnings per share. Research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.